NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/01/2023
Back to search
Official data from USPTO
ALACRITA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ALACRITA
ST13
US500000085557129Class
35, 36, 42
Filing
85557129
Registration
4256669
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/01/2023
Trademark type
Word
Nice classes
35, 36, 42
Filing date
03/01/2012
Registration date
12/11/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2023
Last transaction
06/30/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
LONDON, GB
Examiner
SCHRODY, ALLISON PAIGE
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ALACRITA HOLDINGS LIMITED
A. L. (pessoa física)
Representatives
Jeff Goehring Nixon & Vanderhye P.C.
Technical classification
Nice Classes
Class 35Class 36Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business and market research; business analysisbusiness planningbusiness management and business strategystrategic planning servicesstrategy development services and business consultancy in the fields of pharmaceuticalsbiotechnologylife sciencesmedical productsmedical devices and healthcare industries; business advice regarding the development and commercialization of products in the fields of pharmaceuticalsbiotechnologylife sciencesmedical productsmedical devices and healthcare industries; recruitment and personnel servicespersonnel placement; tax servicestax consultation and accountancy services; advertising and promotional services; arranging business networking meeting opportunities for businesses to meet potential investors and to promote their products; informationconsultancy and advice relating to any of the aforesaid services; management of clinical trials for drugsvaccinesdiagnostic reagentssmall moleculesmedical devicesproviding information management servicesproviding clinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and application for drug approvalproviding independent reviews of clinical trials for business purposes; preparation of reports on clinical trials of drugsvaccinesdiagnostic reagentssmall moleculesmedical devicesproviding informationmanagement and compilation of computerized databases in the field of clinical trials for business purposes; preparing technical business or financial reports on clinical trials of drugsvaccinesdiagnostic reagentssmall moleculesmedical devicespreparation of reports on clinical trials of drugsvaccinesdiagnostic reagentssmall moleculesmedical devices
Class 36
Financial advice for companies in the fields of pharmaceuticalsbiotechnologylife sciencesmedical productsmedical devices and healthcare industries; arranging fundingproviding financing servicesinvestment consultancy; informationconsultancy and advice relating to any of the aforesaid services
Class 42
Research in the field of pharmaceuticalsbiotechnologylife sciencesmedical productsmedical devices and scientific research in the field of healthcare industries; clinical researchmanaging clinical trials for othersproviding medical and scientific research information in the field of clinical trials; testing of pharmaceuticalsdiagnostic reagents or medical products; conducting of clinical trials for others for drugsvaccinesdiagnostic reagentssmall moleculesmedical devices; providing scientific informationpreparation of reports on clinical trials of drugsvaccinesdiagnosticssmall moleculescellular therapiesmedical devicesresearch reagents; scientific researchwriting of medical research and scientific research-related documents and preparing reports on medical research and scientific research-related documents; testing the safety of pharmaceuticalsvaccinesdiagnostic reagentssmall moleculescellular therapiesmedical devicesinformationconsultancy and advice relating to any of the aforesaid services; consultancyadvice and information in the field of development of drugsvaccinesdiagnostic reagentssmall moleculesmedical devices
Publications
History of USPTO decisions and trademark events.
45 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/30/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/30/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
12/06/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/11/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/15/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/15/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/15/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/15/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/15/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/15/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/08/2018
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/08/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/08/2018
ES8R
TEAS SECTION 8 RECEIVED
12/03/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/11/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/24/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
12/11/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/25/2012
PUBO
PUBLISHED FOR OPPOSITION
09/25/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/22/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
08/22/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/22/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
08/22/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/22/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
08/16/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2012
FAXX
FAX RECEIVED
08/14/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/31/2012
GNFR
FINAL REFUSAL E-MAILED
07/31/2012
CNFR
FINAL REFUSAL WRITTEN
07/31/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
07/12/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2012
ALIE
ASSIGNED TO LIE
07/12/2012
FAXX
FAX RECEIVED
07/02/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/19/2012
GNRT
NON-FINAL ACTION E-MAILED
06/19/2012
CNRT
NON-FINAL ACTION WRITTEN
06/19/2012
DOCK
ASSIGNED TO EXAMINER
06/12/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2012
NWAP
NEW APPLICATION ENTERED
03/05/2012
Continuous trademark protection
Get notified about every new filing that threatens ALACRITA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.